Dysregulation of ACSL4 is linked to a variety of diseases, including cancer, neurodegenerative disorders, cardiovascular disease, acute kidney injury, and metabolic disorders (such as obesity and non-alcoholic fatty liver disease). The gene discussed is ACSL4; the disease is metabolic dysfunction-associated steatotic liver disease.